Neurogene Inc (NGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,860 | -16,197 | -11,162 | -6,412 | -24,027 |
| Depreciation Amortization | N/A | N/A | N/A | N/A | 1,884 |
| Accounts receivable | -96 | -318 | -445 | -398 | -17 |
| Other Working Capital | -546 | -1,833 | -1,677 | -629 | 3,597 |
| Other Operating Activity | 2,234 | 2,038 | 1,585 | 1,139 | 1,077 |
| Operating Cash Flow | $-20,268 | $-16,310 | $-11,699 | $-6,300 | $-17,486 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -26 | -16 | -6 | -6 | -88 |
| Purchase Of Investment | -60,703 | N/A | 0 | N/A | -36,475 |
| Sale Of Investment | 13,196 | 18,163 | 12,094 | 6,066 | 12,990 |
| Investing Cash Flow | $-47,533 | $18,147 | $12,088 | $6,060 | $-23,573 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | -2,600 |
| Common Stock Issued | 99,158 | 99,159 | 96 | 72 | 53,130 |
| Other Financing Activity | -6,210 | -6,063 | -76 | 0 | -5,251 |
| Financing Cash Flow | $92,948 | $93,096 | $20 | $72 | $45,279 |
| Exchange Rate Effect | -527 | -466 | -399 | -455 | -320 |
| Beginning Cash Position | 14,906 | 14,906 | 14,906 | 14,906 | 11,006 |
| End Cash Position | 39,526 | 109,373 | 14,916 | 14,283 | 14,906 |
| Net Cash Flow | $24,620 | $94,467 | $10 | $-623 | $3,900 |
| Free Cash Flow | |||||
| Operating Cash Flow | -20,268 | -16,310 | -11,699 | -6,300 | -17,486 |
| Capital Expenditure | -26 | -16 | -6 | -6 | -114 |
| Free Cash Flow | -20,294 | -16,326 | -11,705 | -6,306 | -17,600 |